1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Low-molecular-weight heparin adherence and effects on survival within a randomised phase III lung cancer trial (RASTEN)
(
- Contribution to journal › Article
- 2018
-
Mark
Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer : The RASTEN trial
(
- Contribution to journal › Article
-
Mark
Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer : A sub-study of RASTEN - A randomized trial with low molecular weight heparin
(
- Contribution to journal › Article
- 2003
-
Mark
Pitfalls in the assessment of disability in individuals with low-grade gliomas.
(
- Contribution to journal › Article
- 1984
-
Mark
Normal reference interval for thyrotropin response to thyroliberin : dependence on age, sex, free thyroxin index, and basal concentrations of thyrotropin
(
- Contribution to journal › Article